Cytek Biosciences Stock Technical Analysis
| CTKB Stock | USD 5.00 0.01 0.20% |
As of the 1st of February, Cytek Biosciences shows the Mean Deviation of 2.82, downside deviation of 2.91, and Risk Adjusted Performance of 0.0698. Cytek Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cytek Biosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cytek, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CytekCytek Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Cytek Biosciences Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 6.0 | Buy | 6 | Odds |
Most Cytek analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cytek stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cytek Biosciences, talking to its executives and customers, or listening to Cytek conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytek Biosciences. Projected growth potential of Cytek fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytek Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.735 | Earnings Share (0.11) | Revenue Per Share | Quarterly Revenue Growth 0.015 | Return On Assets |
Investors evaluate Cytek Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cytek Biosciences' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Cytek Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Cytek Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytek Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cytek Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.
Cytek Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytek Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytek Biosciences.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Cytek Biosciences on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Cytek Biosciences or generate 0.0% return on investment in Cytek Biosciences over 90 days. Cytek Biosciences is related to or competes with Varex Imaging, Avanos Medical, Standard Biotools, Clearpoint Neuro, Treace Medical, CeriBell, and Orthopediatrics Corp. Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific adv... More
Cytek Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytek Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytek Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.91 | |||
| Information Ratio | 0.0747 | |||
| Maximum Drawdown | 26.01 | |||
| Value At Risk | (4.88) | |||
| Potential Upside | 6.42 |
Cytek Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytek Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytek Biosciences' standard deviation. In reality, there are many statistical measures that can use Cytek Biosciences historical prices to predict the future Cytek Biosciences' volatility.| Risk Adjusted Performance | 0.0698 | |||
| Jensen Alpha | 0.3221 | |||
| Total Risk Alpha | 0.1503 | |||
| Sortino Ratio | 0.1123 | |||
| Treynor Ratio | 0.3217 |
Cytek Biosciences February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0698 | |||
| Market Risk Adjusted Performance | 0.3317 | |||
| Mean Deviation | 2.82 | |||
| Semi Deviation | 2.72 | |||
| Downside Deviation | 2.91 | |||
| Coefficient Of Variation | 1176.13 | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.08 | |||
| Information Ratio | 0.0747 | |||
| Jensen Alpha | 0.3221 | |||
| Total Risk Alpha | 0.1503 | |||
| Sortino Ratio | 0.1123 | |||
| Treynor Ratio | 0.3217 | |||
| Maximum Drawdown | 26.01 | |||
| Value At Risk | (4.88) | |||
| Potential Upside | 6.42 | |||
| Downside Variance | 8.45 | |||
| Semi Variance | 7.39 | |||
| Expected Short fall | (3.46) | |||
| Skewness | 2.14 | |||
| Kurtosis | 7.17 |
Cytek Biosciences Backtested Returns
Cytek Biosciences appears to be unstable, given 3 months investment horizon. Cytek Biosciences secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Cytek Biosciences, which you can use to evaluate the volatility of the firm. Please makes use of Cytek Biosciences' Downside Deviation of 2.91, mean deviation of 2.82, and Risk Adjusted Performance of 0.0698 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Cytek Biosciences holds a performance score of 8. The firm shows a Beta (market volatility) of 1.12, which signifies a somewhat significant risk relative to the market. Cytek Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Cytek Biosciences is expected to follow. Please check Cytek Biosciences' expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Cytek Biosciences' price patterns will revert.
Auto-correlation | 0.79 |
Good predictability
Cytek Biosciences has good predictability. Overlapping area represents the amount of predictability between Cytek Biosciences time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytek Biosciences price movement. The serial correlation of 0.79 indicates that around 79.0% of current Cytek Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.79 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Cytek Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cytek Biosciences Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cytek Biosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Cytek Biosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cytek Biosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cytek Biosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cytek Biosciences price pattern first instead of the macroeconomic environment surrounding Cytek Biosciences. By analyzing Cytek Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cytek Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cytek Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 27.57 | 16.16 | 14.54 | 13.25 | Days Of Inventory On Hand | 265.83 | 179.31 | 206.21 | 256.5 |
Cytek Biosciences February 1, 2026 Technical Indicators
Most technical analysis of Cytek help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cytek from various momentum indicators to cycle indicators. When you analyze Cytek charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0698 | |||
| Market Risk Adjusted Performance | 0.3317 | |||
| Mean Deviation | 2.82 | |||
| Semi Deviation | 2.72 | |||
| Downside Deviation | 2.91 | |||
| Coefficient Of Variation | 1176.13 | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.08 | |||
| Information Ratio | 0.0747 | |||
| Jensen Alpha | 0.3221 | |||
| Total Risk Alpha | 0.1503 | |||
| Sortino Ratio | 0.1123 | |||
| Treynor Ratio | 0.3217 | |||
| Maximum Drawdown | 26.01 | |||
| Value At Risk | (4.88) | |||
| Potential Upside | 6.42 | |||
| Downside Variance | 8.45 | |||
| Semi Variance | 7.39 | |||
| Expected Short fall | (3.46) | |||
| Skewness | 2.14 | |||
| Kurtosis | 7.17 |
Cytek Biosciences February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cytek stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | (0.04) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 4.97 | ||
| Day Typical Price | 4.98 | ||
| Price Action Indicator | 0.02 | ||
| Market Facilitation Index | 0.23 |
Complementary Tools for Cytek Stock analysis
When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |